Press releases

The conference "Ageing and Neurodegeneration" is co-organised by DZNE, the German Center for Neurodegenerative Diseases and the Max Planck Institute for Biology of Ageing. It brings together cutting edge scientific expertise to create a forum for a high-level scientific…

Targets for Alzheimer therapy

Bonn, April 6^th, 2011. The German Centre for Neurodegenerative Diseases (DZNE) is an attractive address for top scientists from around the world – 53% of the scientific appointments at the DZNE in Bonn are of international origin. Also the US-American Walker Jackson will now…

In June 2010, scientists from the DZNE, the Canadian Institutes of Health Research (CIHR) and the Medical Research Council (MRC, UK) launched “Centers of Excellence in Neurodegeneration” (COEN). From now on, the initiative has its own website. Further information about the…

Munich/Bonn, 2md February 2011. Scientists at the German Center for Neurodegenerative Diseases (DZNE) and the Ludwig-Maximilians Universität Munich have found a promising approach for a possible treatment of so-called frontotemporal dementia, an Alzheimer-like form of…

Zuzana Šišková, scientist in the group of Stefan Remy at the DZNE and the Department of Epileptology at the University Hospital of Bonn, received a Humboldt Research Fellowship for Postdoctoral Researchers. With the award, she will investigate how nerve cells change in…

Scientists from Germany, UK and Italy identify a molecular switch that leads to a sustained increase of calcium in nerve cells and plays a crucial role in the formation of memory and addictive behaviors.

Scientists from Berlin, Bonn and Dundee show in animal models that the diabetes drug Metformin has an effect against one of the main causes of the Alzheimer’s disease.

Tübingen, 21.Oktober 2010.Pathological protein deposits linked to Alzheimer's disease and cerebral amyloid angiopathy can be triggered not only by the administration of pathogenic misfolded protein fragments directly into the brain but also by peripheral administration…

Bonn/Tokyo, 20. Oktober 2010. Yokogawa Electric Corporation and the German Center for Neurodegenerative Diseases (DZNE) announce the signing of an agreement to cooperate in research and development activities to enhance the functions of the CellVoyager^TM CV6000 drug…